2020
DOI: 10.1016/j.apradiso.2020.109307
|View full text |Cite
|
Sign up to set email alerts
|

New core configuration for the fabrication of 125I radioactive sources for cancer treatment

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
2
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
2
1

Relationship

2
1

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 8 publications
1
2
0
Order By: Relevance
“…The authors affirm that if pH is kept high, the Na 125 I solution will remain stable not releasing the 125 I À for silver binding. Both of these issues were confirmed by Daruich de Souza et al [39].…”
Section: Characteristic Of the Isotope And Other Problems (Ph Reaction Volume Vial Type)supporting
confidence: 57%
“…The authors affirm that if pH is kept high, the Na 125 I solution will remain stable not releasing the 125 I À for silver binding. Both of these issues were confirmed by Daruich de Souza et al [39].…”
Section: Characteristic Of the Isotope And Other Problems (Ph Reaction Volume Vial Type)supporting
confidence: 57%
“…A capsule of biocompatible material that surrounds the core, most commonly titanium or stainless steel [ 15 ].…”
Section: Methodsmentioning
confidence: 99%
“…Depending to the treatment that the seed is being used, the seed activity will vary. For example, to treat prostate cancer Iodine-125 seed with activities averaging 30 MBq [ 15 ]. For use in RSL, several authors report activities between 1.10 to 13.00 MBq (0.03 to 0.35 mCi) [ 16 17 ].…”
Section: Methodsmentioning
confidence: 99%